Mettler-Toledo International Inc. (NYSE:MTD) Director Sells $99,693.00 in Stock

Mettler-Toledo International Inc. (NYSE:MTD) Director Elisha W. Finney sold 76 shares of the firm’s stock in a transaction on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the transaction, the director now directly owns 240 shares of the company’s stock, valued at approximately $314,820. This trade represents a 24.05 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Mettler-Toledo International Stock Performance

NYSE:MTD opened at $1,179.58 on Friday. The company has a market cap of $24.89 billion, a price-to-earnings ratio of 31.80, a P/E/G ratio of 4.16 and a beta of 1.16. The stock’s fifty day moving average price is $1,385.96 and its two-hundred day moving average price is $1,400.67. Mettler-Toledo International Inc. has a 52-week low of $1,041.49 and a 52-week high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, topping analysts’ consensus estimates of $10.00 by $0.21. The company had revenue of $954.54 million during the quarter, compared to the consensus estimate of $941.93 million. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. On average, equities analysts predict that Mettler-Toledo International Inc. will post 40.37 EPS for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Family Firm Inc. bought a new stake in shares of Mettler-Toledo International during the second quarter worth approximately $25,000. Blue Trust Inc. grew its holdings in Mettler-Toledo International by 242.9% during the 3rd quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock worth $34,000 after acquiring an additional 17 shares during the period. Ashton Thomas Securities LLC bought a new stake in shares of Mettler-Toledo International during the 3rd quarter valued at $37,000. Rothschild Investment LLC acquired a new position in shares of Mettler-Toledo International in the 2nd quarter valued at $42,000. Finally, Itau Unibanco Holding S.A. bought a new stake in Mettler-Toledo International in the second quarter valued at about $42,000. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

MTD has been the subject of a number of recent research reports. Wells Fargo & Company reduced their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a report on Monday, November 11th. Evercore ISI raised their price target on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 1st. JPMorgan Chase & Co. upped their price objective on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a research note on Monday, August 5th. Robert W. Baird dropped their target price on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a report on Monday, November 11th. Finally, Stifel Nicolaus decreased their price target on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research note on Monday, November 11th. Two analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $1,338.75.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.